pcDNA3-HA-ADH Citations (5)
Originally described in: Johnson Lab PlasmidsUnpublished
Articles Citing pcDNA3-HA-ADH
| Articles |
|---|
| Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer. Wang J, Nikhil K, Viccaro K, Chang L, White J, Shah K. BMC Biol. 2017 Feb 13;15(1):10. doi: 10.1186/s12915-016-0335-5. PubMed |
| Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1. Gasparetto M, Pei S, Minhajuddin M, Khan N, Pollyea DA, Myers JR, Ashton JM, Becker MW, Vasiliou V, Humphries KR, Jordan CT, Smith CA. Haematologica. 2017 Jun;102(6):1054-1065. doi: 10.3324/haematol.2016.159053. Epub 2017 Mar 9. PubMed |
| Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers. Solomon H, Dinowitz N, Pateras IS, Cooks T, Shetzer Y, Molchadsky A, Charni M, Rabani S, Koifman G, Tarcic O, Porat Z, Kogan-Sakin I, Goldfinger N, Oren M, Harris CC, Gorgoulis VG, Rotter V. Oncogene. 2018 Mar;37(12):1669-1684. doi: 10.1038/s41388-017-0060-8. Epub 2018 Jan 18. PubMed |
| The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer. Voronkova MA, Rojanasakul LW, Kiratipaiboon C, Rojanasakul Y. Mol Cell Biol. 2020 Jan 3;40(2). pii: MCB.00307-19. doi: 10.1128/MCB.00307-19. Print 2020 Jan 3. PubMed |
| Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma. Schoenfeld DA, Zhou R, Zairis S, Su W, Steinbach N, Mathur D, Bansal A, Zachem AL, Tavarez B, Hasson D, Bernstein E, Rabadan R, Parsons R. Mol Cancer Res. 2022 Aug 5;20(8):1193-1207. doi: 10.1158/1541-7786.MCR-21-1039. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.